Assessing risk to benefit ratio in antiepileptic drug therapy

By Perucca E.   Beghi E.   Dulac O.   Shorvon S.   Tomson T.  

Epilepsy Research, Vol. 41, Iss. 2, 2000-08 ,pp. : 107-139

Elsevier

Access to resources Recommend Favorite

Drug Therapy of Post-Stroke Aphasia: A Review of Current Evidence

By Berthier Marcelo  

Neuropsychology Review, Vol. 21, Iss. 3, 2011-09 ,pp. : 302-317

Springer Publishing Company

Access to resources Recommend Favorite

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug

By French J.   Edrich P.   Cramer J.A.  

Epilepsy Research, Vol. 47, Iss. 1, 2001-11 ,pp. : 77-90

Elsevier

Access to resources Recommend Favorite

Metabolic Parameters of Epilepsy: Adjuncts to Established Antiepileptic Drug Therapy: Dedicated to Dr. Anders Hamberger

By van Gelder Nico M.   Sherwin Allan L.  

Neurochemical Research, Vol. 28, Iss. 2, 2003-02 ,pp. : 353-365

Springer Publishing Company

Access to resources Recommend Favorite

Effect of chronic antiepileptic drug therapy on california achievement test scores - Its effect on learning in epileptic children

By Irianto D.   Tennison M.   Kankirawatana P.   Richardson Bowman M.   Greenwood R.   Lewis D.   Burchinal M.  

Journal of Epilepsy, Vol. 11, Iss. 4, 1998-07 ,pp. : 208-214

Elsevier

Access to resources Recommend Favorite